FDA Recalls libigrow RED DRAGON+ Capsules for Undeclared Sildenafil and Tadalafil
Pyramids Wholesale Inc. is recalling libigrow RED DRAGON+ capsules nationwide because they contain undeclared sildenafil and tadalafil, prescription medications not approved by the FDA for this product.
The agency’s classification
FDA (Drugs): Class I
Class I is a situation in which there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The FDA classified this as a Class I recall, which establishes a minimum severity of Severe per the rubric. The product contains undeclared prescription drugs without FDA approval, creating potential health risks. No illnesses or injuries have been reported.
Plain-English summary
The FDA has issued a Class I recall of libigrow RED DRAGON+ (2 capsules per box, UPC 7 05105 83073 5), manufactured by Pyramids Wholesale Inc. The product was marketed without an approved New Drug Application (NDA) or Abbreviated New Drug Application (ANDA) and contains undeclared sildenafil and tadalafil, both of which are prescription medications.
The affected product has been distributed nationwide in the United States, and all lots are included in this recall.
Consumers who have obtained this product should stop using it immediately. If you have taken this product, consult your healthcare provider. Do not discard in household trash; contact a pharmacy or local waste disposal facility for proper disposal instructions.
The recalled product
- Product
- libigrow RED DRAGON+, Maximum Strength Formula, 2 capsules per box, UPC 7 05105 83073 5.
- Manufacturer
- Pyramids Wholesale Inc.
- Category
- Drug
- Affected units
- 7
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- All lots
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 11 recalled by Pyramids Wholesale Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 11 products in this recall →Related recalls
Same manufacturer · Pyramids Wholesale Inc.
See all →- SevereSamurai-X Honey 6800 Recalled for Undeclared Drug Ingredients
FDA (Drugs) · 2024-05-01
- SevereThe GOAT Sublingual Strip Recalled for Undeclared Prescription Drug Ingredients
FDA (Drugs) · 2024-05-01
- SevereMale Sexual Enhancement Product Recalled for Undeclared Pharmaceutical Ingredients
FDA (Drugs) · 2024-05-01
- SevereHoney product recalled nationwide for undeclared sildenafil and tadalafil
FDA (Drugs) · 2024-05-01
- SeverePink Pussycat Honey recalled for undeclared sildenafil and tadalafil content
FDA (Drugs) · 2024-05-01
Same hazard · sildenafil
See all →- SevereFDA Recalls X10 Supplement Containing Undeclared Sildenafil and Tadalafil
FDA (Food) · 2026-10-14
- SevereBlue Bull male enhancement supplement pouches contain undeclared sildenafil
FDA (Food) · 2026-04-15
- SevereRed Bull male enhancement supplement pouches contain undeclared sildenafil
FDA (Food) · 2026-04-15
- SevereBoner Bears Honey Male Enhancement contains undeclared pharmaceutical drugs
FDA (Food) · 2026-04-15
- SevereMR. 7 Super capsules recalled as Class I over undeclared sildenafil
FDA (Drugs) · 2026-03-11
Similar recalls
- SevereFDA Recalls Unapproved Libigrow XXXTREME Capsules Containing Undeclared Ingredients
FDA (Drugs) · 2013-05-22
- SevereFDA Recalls Libigrow Capsules for Undeclared Active Ingredients
FDA (Drugs) · 2013-05-22
- SevereRED MAMMOTH 400 mg Capsules Recalled for Undeclared Active Pharmaceutical Ingredients
FDA (Drugs) · 2022-02-23
- CriticalFDA Recalls Rhino 69 Extreme 50000 for Undeclared Tadalafil
FDA (Drugs) · 2018-05-30
- SevereRISE UP RED EDITION Capsules recalled for undeclared tadalafil
FDA (Drugs) · 2022-03-02
- CriticalTornado Male Enhancement Supplement Recalled for Undeclared Prescription Drugs
FDA (Drugs) · 2017-07-19